Abstract
In type 2 diabetes, the onset and progression of complications is significantly delayed by improving glycaemic control. However, the proportion of patients reaching and sustaining guideline recommendations for glycaemic targets remains unacceptably low. Recent clinical trials and predictive physiologically based mathematical simulations (Archimedes model) indicate that benefits can be enhanced with earlier intervention and timely achievement of glycaemic targets. This article reviews the evidence for early intervention, showing that intensive approaches, including earlier introduction of combination therapy, allow more patients to achieve glycaemic targets and hence reduce complications and delay disease progression.
Original language | English |
---|---|
Pages (from-to) | 1309-1316 |
Number of pages | 8 |
Journal | International Journal of Clinical Practice |
Volume | 59 |
Issue number | 11 |
DOIs | |
Publication status | Published - Nov 2005 |
Externally published | Yes |
Keywords
- Archimedes model
- Combination therapy
- Early intervention
- Glycaemic control
- Type 2 diabetes